dysprosium dtpa has been researched along with dysprosium in 16 studies
Studies (dysprosium dtpa) | Trials (dysprosium dtpa) | Recent Studies (post-2010) (dysprosium dtpa) | Studies (dysprosium) | Trials (dysprosium) | Recent Studies (post-2010) (dysprosium) |
---|---|---|---|---|---|
26 | 0 | 0 | 577 | 3 | 207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (81.25) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kiihne, S; Weisskoff, RM | 1 |
Bauer, WR; Schulten, K | 1 |
Higgins, CB; Saeed, M; Wendland, MF | 1 |
Di Bartolo, N; Hetherington, EL; Knapp, FF; Lambrecht, RM; Mirzadeh, S; Smith, SV | 1 |
Boxerman, JL; Rosen, BR; Weisskoff, RM; Zuo, CS | 1 |
Constable, RT; Gore, JC; Kennan, RP; McCarthy, G; Puce, A | 1 |
Chu, WJ; Elgavish, GA | 1 |
Allen, PS; Martin, WR; Ye, FQ | 1 |
Bauer, M; Krause, W; Muschick, P; Press, WR; Schuhmann-Giampieri, G | 1 |
Koenig, SH | 1 |
Brechbiel, MW; Brooks, RA; Bulte, JW; Frank, JA; Holla, M; Vymazal, J; Wu, C | 1 |
Colet, JM; Fahlvik, AK; Fossheim, SL; Kellar, KE; Klaveness, J; Mansson, S; Rongved, P | 1 |
Fossheim, SL; Kellar, KE; Spiller, M | 1 |
Colby, AL; Frederique, DE; Miles, RD; Pond, BV; Roan, MA; Troughton, JS; Wenzel, TJ; Zomlefer, K | 1 |
Mattrey, RF; Vera, DR | 1 |
Botteman, F; Laurent, S; Muller, RN; Sherry, AD; Vander Elst, L; Zhang, S | 1 |
16 other study(ies) available for dysprosium dtpa and dysprosium
Article | Year |
---|---|
MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
Topics: Contrast Media; Dextrans; Dysprosium; Erythrocytes; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; In Vitro Techniques; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid | 1992 |
Theory of contrast agents in magnetic resonance imaging: coupling of spin relaxation and transport.
Topics: Contrast Media; Dysprosium; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Iron; Kupffer Cells; Magnetic Resonance Imaging; Models, Biological; Models, Theoretical; Organometallic Compounds; Oxides; Pentetic Acid | 1992 |
Magnetic resonance contrast media for myocardial imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats | 1990 |
[166Dy]dysprosium/[166Ho]holmium in vivo generator.
Topics: Animals; Bone and Bones; Bone Marrow; Dysprosium; Holmium; Humans; Kinetics; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentetic Acid; Radioisotopes; Serum Albumin; Tissue Distribution | 1995 |
Microscopic susceptibility variation and transverse relaxation: theory and experiment.
Topics: Animals; Computer Simulation; Contrast Media; Diffusion; Dysprosium; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Microspheres; Models, Biological; Models, Chemical; Models, Theoretical; Monte Carlo Method; Organometallic Compounds; Particle Size; Pentetic Acid; Polystyrenes; Protons | 1994 |
Functional NMR imaging using fast spin echo at 1.5 T.
Topics: Body Water; Brain; Diffusion; Dysprosium; Hemoglobins; Humans; Image Enhancement; Magnetic Resonance Imaging; Microcirculation; Models, Structural; Models, Theoretical; Organometallic Compounds; Oxyhemoglobins; Particle Size; Pentetic Acid; Photic Stimulation; Polystyrenes; Regional Blood Flow; Visual Cortex; Water | 1994 |
Gadolinium and dysprosium chelates of DTPA-amide-dextran: synthesis, 1H NMR relaxivity, and induced 23Na NMR shift.
Topics: Amides; Chelating Agents; Dextrans; Dysprosium; Gadolinium; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Protons; Sodium Isotopes | 1995 |
Estimation of brain iron in vivo by means of the interecho time dependence of image contrast.
Topics: Adult; Body Water; Brain; Brain Diseases; Confidence Intervals; Contrast Media; Dysprosium; Frontal Lobe; Gels; Globus Pallidus; Humans; Image Enhancement; Iron; Magnetic Resonance Imaging; Microspheres; Neuroglia; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Putamen; Reproducibility of Results; Thalamus | 1996 |
Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
Topics: Animals; Biological Products; Bismuth; Bone and Bones; Cerium; Chelating Agents; Chemical Phenomena; Chemistry, Physical; Contrast Media; Dysprosium; Erythrocytes; Humans; Lanthanum; Lead; Liver; Lutetium; Minerals; Organometallic Compounds; Osmolar Concentration; Partial Thromboplastin Time; Pentetic Acid; Phantoms, Imaging; Praseodymium; Protein Binding; Rabbits; Radiographic Image Enhancement; Rats; Tissue Distribution; Tomography, X-Ray Computed; Viscosity; Ytterbium | 1996 |
Solvent relaxation by uniformly magnetized solute spheres. The classical-quantal connection.
Topics: Contrast Media; Dysprosium; Humans; Magnetic Resonance Imaging; Microspheres; Monte Carlo Method; Organometallic Compounds; Particle Size; Pentetic Acid; Polystyrenes; Water | 1998 |
Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry.
Topics: Contrast Media; Dysprosium; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1998 |
Investigation of lanthanide-based starch particles as a model system for liver contrast agents.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Metals, Rare Earth; Organometallic Compounds; Particle Size; Pentetic Acid; Rats; Rats, Wistar; Spectrophotometry, Atomic; Tissue Distribution | 1999 |
NMRD investigation of DyDTPA- and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity.
Topics: Contrast Media; Dysprosium; Gadolinium DTPA; Humans; Organometallic Compounds; Pentetic Acid; Polyethylene Glycols; Starch | 1999 |
Dysprosium(III)-diethylenetriaminepentaacetate complexes of aminocyclodextrins as chiral NMR shift reagents.
Topics: Cyclodextrins; Dysprosium; Indicators and Reagents; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Pentetic Acid; Stereoisomerism | 2000 |
A molecular CT blood pool contrast agent.
Topics: Animals; Contrast Media; Dysprosium; Liver Neoplasms, Experimental; Macrophage Activation; Molecular Weight; Organometallic Compounds; Pentetic Acid; Rabbits; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2002 |
Dy-complexes as high field T2 contrast agents: influence of water exchange rates.
Topics: Body Water; Contrast Media; Dysprosium; Humans; Ligands; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 2002 |